HSBC Holdings
VOR icon

HSBC Holdings’s Vor Biopharma VOR Stock Holding History

HSBC Holdings’s Portfolio VOR Stock Details VOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-2,236
Closed -$32.6K – 3257
2025
Q1 		$32.6K Hold
2,236
– – ﹤0.01% 2940
2024
Q4 		$48.8K Hold
2,236
– – ﹤0.01% 2989
2024
Q3 		$32.5K Sell
2,236
-216
-9% -$3.94K ﹤0.01% 2915
2024
Q2 		$51K Buy
2,452
+1,567
+177% +$50.7K ﹤0.01% 2814
2024
Q1 		$42K Buy
+885
New +$38.9K ﹤0.01% 2948

Other funds holding VOR

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

HSBC Holdings's VOR Position: Q2 2025 in Review

HSBC Holdings sold out of Vor Biopharma (VOR) in Q2 2025, closing a stake of 2,236 shares — an estimated $32.6K sold.

HSBC Holdings first reported a position in VOR in Q1 2024 and held it in 5 quarters. The position peaked at $51K in Q2 2024. 35 funds tracked by Wall St. Rank hold VOR as of Q2 2025.

  • HSBC Holdings reported no remaining Vor Biopharma position as of Q2 2025 after selling out during the quarter.
  • HSBC Holdings sold 2,236 Vor Biopharma shares in Q2 2025, an estimated $32.6K.
  • HSBC Holdings first reported a position in Vor Biopharma in Q1 2024 and held it in 5 quarters.
  • HSBC Holdings's Vor Biopharma position peaked at $51K in Q2 2024.
  • 35 funds tracked by Wall St. Rank held Vor Biopharma as of Q2 2025.

Based on HSBC Holdings's 13F filing for Q2 2025, filed 13 Aug 2025.